Precision Diagnosis and Management of Inflammatory Bowel Diseases in the Context of Personalized Medicine

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 523

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania
2. Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania
Interests: pharmacology; alternative therapies; biochemistry; public health; therapeutics; one health; sustainability in health; ecology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are recognized as chronic, progressive, non-curable diseases that are immune-mediated in adults and children alike. IBDs can cause significant morbidity and may lead to cancer, fistulas, infections, and strictures. The symptoms of IBDs are variable, and the delayed diagnosis of IBDs is common, especially in Crohn's disease, which is associated with adverse outcomes. Early diagnosis and the prompt establishment of optimal, personalized treatments are essential conditions for maximizing the patient's health status.

The main topics of this Special Issue of Diagnostics cover the following areas:

  • Accurate diagnosis in IBDs, accuracy of blood biomarkers for the prediction of IBD, new biomarkers for IBDs, genetic changes associated with the presence of IBDs, the role of miRNA in predicting IBDs, and genetic phenotypes in IBDs;
  • The role of modern endoscopic techniques in the diagnosis of IBDs and their complications, and modern advances such as endoscopic molecular imaging, etc.;
  • Comorbidities associated with IBDs on the patient’s health (increased risk of NAFLD, cardiovascular diseases, cancer risk, etc.).

Original research articles and reviews are equally welcome.

Prof. Dr. Delia Mirela Tit
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bowel disease
  • Crohn’s disease
  • ulcerative colitis
  • digestive system
  • diagnostic techniques
  • early diagnosis
  • personalized medicine

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop